1039803-54-7

Basic information

• Product Name: 5-bromo-N-[(4-fluorophenyl)methyl]pyridin-2-amine
• Synonyms: 5-bromo-N-[(4-fluorophenyl)methyl]pyridin-2-amine;2-PYRIDINAMINE, 5-BROMO-N-[(4-FLUOROPHENYL)METHYL]-;5-BROMO-N-[(4-FLUOROPHENYL)METHYL]-2-PYRIDINAMINE;(5-Bromo-pyridin-2-yl)-(4-fluoro-benzyl)-amine
• CAS NO: 1039803-54-7
• Molecular Formula: C₁₂H₁₀BrFN₂
• Molecular Weight: 281.1236032
• Mol File: 1039803-54-7.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 5-bromo-N-[(4-fluorophenyl)methyl]pyridin-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 5-bromo-N-[(4-fluorophenyl)methyl]pyridin-2-amine(1039803-54-7)
• EPA Substance Registry System: 5-bromo-N-[(4-fluorophenyl)methyl]pyridin-2-amine(1039803-54-7)

Safety Data

• Hazardous Substances Data: 1039803-54-7(Hazardous Substances Data)

Upstream product

• 766-11-0 5-bromo-2-fluoropyridine 
• 140-75-0 para-fluorobenzylamine 
• 504-29-0 2-aminopyridine 
• 459-57-4 4-fluorobenzaldehyde 
• 1692-02-0 N-(4-fluorobenzyl)pyridine-2-amine 
• 624-28-2 2,5-dibromopyridine 

Relevant articles and documents

LIPOXYGENASE INHIBITORS

Various embodiments of the present disclosure are directed to compounds having Formula I, Formula II, Formula IIA, Formula III, Formula IIIA, Formula IIIB, and/or pharmaceutically acceptable salts thereof. The compounds can be suitable for inhibiting lipoxygenases and/or treating associated diseases. In some embodiments, subject compounds are used to prepare a composition that is effective in treating neurodegenerative diseases.

Substituted N-(2-aminophenyl)-benzamides, (E)-N-(2-aminophenyl)-acrylamides and their analogues: Novel classes of histone deacetylase inhibitors

Inhibition of histone deacetylases (HDACs) is emerging as a new strategy in human cancer therapy. Novel 2-aminophenyl benzamides and acrylamides, that can inhibit human HDAC enzymes and induce hyperacetylation of histones in human cancer cells, have been